Report #2842362

Overview

Sex

Female

Age

Age unknown

State

MO

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

Administration after a below temperature excursion of 29.9°F as the minimum reached; This non-serious case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in a female patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 44TR9) for prophylaxis. On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced incorrect storage of drug (Verbatim: Administration after a below temperature excursion of 29.9°F as the minimum reached). The outcome of the incorrect storage of drug was not applicable. Additional Information: GSK Receipt Date: 15-MAY-2025 The registered nurse asked the recommendations after giving several vaccines that were exposed to a below temperature excursion reported of 29.9 degree Fahrenheit as the lowest reached for these products that were administered to a patient which led to incorrect storage of drug. The vaccine administration facility was the same as primary reporter.; Sender's Comments: US-GSK-US2025061537:same reporter US-GSK-US2025061548: US-GSK-US2025061546:Same reporter,Different patient